Adaptive confirmation of treatable arrhythmia in implantable cardiac stimulus devices
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61N-001/39
A61N-001/365
A61N-001/362
A61B-005/0464
출원번호
US-0826241
(2010-06-29)
등록번호
US-9149637
(2015-10-06)
발명자
/ 주소
Warren, Jay A.
Sanghera, Rick
Allavatam, Venugopal
출원인 / 주소
CAMERON HEALTH, INC.
대리인 / 주소
Seager, Tufte & Wickhem LLP
인용정보
피인용 횟수 :
2인용 특허 :
161
초록▼
Methods and devices for adjusting therapy delivery decisions in an implantable cardiac stimulus device by observing cardiac activity following an initial identification of a treatable condition. In some examples, cardiac activity that appears benign is quantified and a therapy confirmation threshold
Methods and devices for adjusting therapy delivery decisions in an implantable cardiac stimulus device by observing cardiac activity following an initial identification of a treatable condition. In some examples, cardiac activity that appears benign is quantified and a therapy confirmation threshold is adjusted according to how much apparently benign cardiac activity is seen after an initial identification of a treatable condition. In other examples, a new threshold is applied following the initial identification of treatable condition, removing historical data preceding the initial identification from subsequent therapy delivery decisions.
대표청구항▼
1. A method of operation in an implantable cardiac stimulus device (ICSD) comprising a housing that contains a battery power source and operational circuitry that operates by analyzing cardiac signals from implanted electrode(s) in order to determine whether a treatable arrhythmia is detected, the m
1. A method of operation in an implantable cardiac stimulus device (ICSD) comprising a housing that contains a battery power source and operational circuitry that operates by analyzing cardiac signals from implanted electrode(s) in order to determine whether a treatable arrhythmia is detected, the method comprising: the ICSD making an initial determination that a treatable cardiac arrhythmia is occurring;the ICSD preparing to deliver therapy in response to the initial determination and, while preparing to deliver therapy, observing whether indications of benign cardiac rhythm are detected;when the ICSD is prepared to deliver therapy, applying Confirmation criteria to confirm the treatable cardiac arrhythmia is ongoing, the Confirmation criteria comprising a Therapy threshold and the Confirmation criteria is applied by: counting intervals between events detected from sensed cardiac signals that are shorter than a short interval threshold to generate a Short Interval Count (SIC); andcomparing SIC to the Therapy threshold; andif the Confirmation criteria are met, delivering therapy from the ICSD;wherein the method comprises the ICSD changing the Confirmation criteria in response to identification of one or more of the indications of benign cardiac rhythm while the ICSD is preparing to deliver therapy by increasing the Therapy threshold to require a larger SIC value;further wherein the Confirmation criteria are actively updated and re-applied until either therapy is delivered or the ICSD determines that therapy is not needed; further wherein;the ICSD uses an event detection method in which events are detected from sensed cardiac signals, and intervals between the detected events are used to estimate cardiac rate for use in the initial determination that a treatable cardiac arrhythmia is occurring. 2. The method of claim 1 wherein preparing to deliver therapy comprises charging an output capacitor to a therapy level for delivery of therapy. 3. The method of claim 1 wherein preparing to deliver therapy comprises waiting for a timer to expire after the initial determination and before delivering therapy. 4. The method of claim 1 wherein preparing to deliver therapy comprises waiting for a predetermined number of cardiac events to be detected after the initial determination and before delivering therapy. 5. The method of claim 1 wherein an indication of benign cardiac rhythm is identified when a cardiac rate slower than a slow-rate threshold is detected. 6. The method of claim 1 comprising further modifying the Confirmation criteria if, after modification of the Confirmation criteria in response to indications of benign cardiac rhythm, a treatable cardiac arrhythmia is detected. 7. The method of claim 1 wherein, if indications of a benign cardiac rhythm are identified and the Therapy threshold is increased, if indications of treatable cardiac arrhythmia follow, the method further comprises modifying the Confirmation criteria by reducing the Therapy threshold. 8. The method of claim 1 wherein: the ICSD uses the event detection method and makes the initial determination by determining whether detected events have morphologies indicating that a treatable cardiac arrhythmia is occurring; and the indications of benign rhythm comprise morphology data indicating that the treatable cardiac arrhythmia is not ongoing; andthe morphology of detected events is analyzed by the ICSD using one or more of: detected event width; detected event amplitude; detected event correlation to template or lack thereof; and event-to-event variability. 9. An implantable cardiac stimulus device (ICSD) comprising a housing that contains a battery power source and operational circuitry that operates by analyzing cardiac signal data from implanted electrodes in order to determine whether a treatable arrhythmia is detected, ICSD configured to perform a method of verifying therapy delivery comprising: the ICSD making an initial determination that a treatable cardiac arrhythmia is occurring;after making an initial determination that a treatable cardiac arrhythmia is occurring, the ICSD preparing to deliver therapy;while the ICSD is preparing to deliver therapy, observing whether indications of benign cardiac rhythm are detected;when the ICSD is prepared to deliver therapy, the ICSD applying Confirmation criteria to ensure the treatable cardiac arrhythmia is ongoing, the Confirmation criteria comprising a Therapy threshold and the Confirmation criteria is applied by: counting intervals between events detected from sensed cardiac signals that are shorter than a short interval threshold to generate a Short Interval Count (SIC); andcomparing SIC to the Therapy threshold; andif the Confirmation criteria are met, the ICSD delivering therapy;wherein the method comprises the ICSD changing the Confirmation criteria in response to identification of one or more indications of a benign cardiac rhythm while the ICSD is preparing to deliver therapy by increasing the Therapy threshold to require a larger SIC value;further wherein the Confirmation criteria are actively updated and re-applied until either therapy is delivered or the ICSD determines that therapy is not needed; further wherein;the operational circuitry is configured to use an event detection method in which cardiac events are detected from the sensed cardiac signals, and intervals between the detected cardiac events are used by the controller to estimate cardiac rate for use in the initial determination that a treatable cardiac arrhythmia is occurring. 10. The ICSD of claim 9 wherein the operational circuitry includes: an output capacitor and a charger coupled to the output capacitor such that the output capacitor can be charged by the charger to temporarily store therapeutic energy prior to delivering therapy; input circuitry for receiving sensed cardiac signals from the implanted electrodes and amplifying and filtering the input signals;a controller coupled to the input circuitry, output capacitor, output circuitry, and charger and controlling the functions thereof, the controller configured to determine whether a treatable arrhythmia is detected and to perform the method of verifying therapy delivery; anda battery providing power to the operational circuitry. 11. The ICSD of claim 10 wherein the ICSD prepares to deliver therapy by charging the output capacitor to a therapy level for delivery of therapy. 12. The ICSD of claim 9 wherein the ICSD prepares to deliver therapy by waiting for a timer to expire after the initial determination and before delivering therapy. 13. The ICSD of claim 9 wherein the ICSD prepares to deliver therapy by waiting for a predetermined number of cardiac events to be detected after the initial determination and before delivering therapy. 14. The ICSD of claim 9 wherein, in the method of verifying therapy delivery, an indication of benign cardiac rhythm is identified when a cardiac rate below a slow-rate threshold is detected. 15. The ICSD of claim 9 wherein, in the method of verifying therapy delivery, if indications of a benign cardiac rhythm are identified and the Therapy threshold is increased, if indications of treatable cardiac arrhythmia follow, the method further comprises modifying the Confirmation criteria by reducing the Therapy threshold. 16. The ICSD of claim 9 wherein the housing comprises either: a single unit protecting the battery power source and operational circuitry, the operational circuitry including a processor and associated logic and memory to allow carrying out of the steps of the method; ora plurality of units containing and protecting the battery and operational circuitry in a number of separate elements. 17. The ICSD of claim 9 wherein: the ICSD uses an event detection method and makes the initial determination by determining whether detected events have morphologies indicating that a treatable cardiac arrhythmia is occurring; andthe indications of benign rhythm comprise morphology data indicating that the treatable cardiac arrhythmia is not ongoing; and the morphology of detected events is analyzed by the ICSD using one or more of:detected event width;detected event amplitude;detected event correlation to template or lack thereof;and event-to-event variability. 18. An implantable cardiac stimulus device (ICSD) that operates by analyzing cardiac signal data from implanted electrodes in order to determine whether a treatable arrhythmia needs therapy by: detecting cardiac events using the implanted electrodes;establishing an X/Y Counter with X indicating a number of Treatable detected cardiac arrhythmia events out of a set of Y detected cardiac events; anddetermining whether the X/Y Counter meets at least a Therapy threshold condition and, if so, the ICSD determining that a treatable arrhythmia needs therapy and beginning to prepare for therapy delivery, wherein the Therapy threshold condition calls for X/Y to yield 18 out of 24 detected cardiac events as Treatable detected cardiac arrhythmia events;wherein the ICSD is also configured to perform a method of verifying therapy delivery when the ICSD begins to prepare for therapy delivery, the method of verifying therapy delivery comprising:resetting the X/Y counter such that X is zero;detecting cardiac events and refilling the X/Y counter while the ICSD prepares to deliver therapy;determining that the ICSD is ready to deliver therapy;once the ICSD is ready to deliver therapy, if the X/Y counter exceeds a Confirmation threshold condition, delivering therapy; or, if not, waiting for additional detected cardiac events, in which the Confirmation threshold condition calls for X/Y to yield 12/16 detected cardiac events as Treatable detected cardiac arrhythmia events. 19. The ICSD of claim 18 wherein the ICSD prepares to deliver therapy by charging an output capacitor to a therapy level for delivery of therapy. 20. The ICSD of claim 18 wherein the ICSD prepares to deliver therapy by waiting for a timer to expire before delivering therapy. 21. The ICSD of claim 18 wherein the ICSD prepares to deliver therapy by waiting for a predetermined number of cardiac events to be detected before delivering therapy. 22. The ICSD of claim 18 wherein the ICSD is configured to identify Treatable cardiac arrhythmia events using an estimated cardiac rate. 23. The ICSD of claim 18 wherein the ICSD is configured to identify Treatable cardiac arrhythmia events using morphology analysis including one or more of: detected cardiac event width;detected cardiac event amplitude;detected cardiac event correlation to template or lack thereof;and variability from one detected cardiac event to another detected cardiac event. 24. The ICSD of claim 18 wherein the ICSD comprises a housing and operational circuitry in the housing including: an output capacitor and a charger, the output capacitor configured to receive and temporarily store therapeutic energy from the charger for purposes of preparing to deliver therapy;input circuitry for receiving input signals from the implanted electrodes and amplifying and filtering the input signals;a controller coupled to the input circuitry, output capacitor, output circuitry, and charger and controlling the functions thereof, the controller configured to determine whether a treatable cardiac arrhythmia is detected and to perform the method of verifying therapy delivery; anda battery providing power to the operational circuitry. 25. An implantable cardiac stimulus device (ICSD) comprising a canister housing operational circuitry for the ICSD, the operational circuitry including a defibrillation capacitor for storing defibrillation energy and a charging circuit for charging the defibrillation capacitor to a therapeutic energy level, the canister including at least one electrode thereon, and a lead electrode coupled to the canister and carrying electrodes coupled to the operational circuitry, the operational circuitry being configured to perform a method comprising: capturing cardiac signals from the electrodes;determining that a tachyarrhythmia or fibrillation is occurring and needs therapy;activating the charging circuit to charge the defibrillation capacitor;detecting cardiac events after the charging circuit is activated and keeping a long interval count by: a) establishing an initial value for the long interval count when the charging circuit is activated, andb) incrementing the long interval count when a long interval between two detected cardiac events occurs, orc) decrementing the long interval count when a short interval between two detected cardiac events occurs, the decrementing step being limited by the initial value;determining whether charging is complete, and,if so, determining whether a Confirmation condition is met, the Confirmation condition requiring a series of detected cardiac events to indicate therapy delivery, wherein the series of detected cardiac events has a length defined by the long interval count, andif so, delivering therapy to the patient.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (161)
Bonnet, Jean-Luc; Henry, Christine, Active implantable medical device, in particluar a pacemaker, defibrillator and/or cardiovertor, capable of eliminating detection event artifacts.
Wilson Stephen G. (Stanmore AUX) Stephens Anthony C. (Willoughby AUX), Apparatus and method for controlling tachyarrhythmia confirmation in response to patient history.
Bardy, Gust H.; Rissmann, William J.; Ostroff, Alan H.; Erlinger, Paul J.; Allavatam, Venugopal, Apparatus and method of arrhythmia detection in a subcutaneous implantable cardioverter/defibrillator.
Bardy,Gust H.; Rissmann,William J.; Ostroff,Alan H.; Erlinger,Paul J.; Allavatam,Venugopal, Apparatus and method of arrhythmia detection in a subcutaneous implantable cardioverter/defibrillator.
Bardy Gust H. (Seattle WA) Olson Walter H. (North Oaks MN) Peterson David K. (Mounds View MN) Taepke Robert T. (Fridley MN), Apparatus for detection of and discrimination between tachycardia and fibrillation and for treatment of both.
Kraf Teri J. (Point Pleasant NJ) Frisbie William R. (Sag Harbor NY) Rosner Allan (East Patchogue NY), Autonomic neuropathy detection and method of analysis.
Robert W. Stadler ; Shannon Nelson, Axis shift analysis of electrocardiogram signal parameters especially applicable for multivector analysis by implantable medical devices, and use of same.
Dahl Roger W. (Andover MN) Swanson David K. (Roseville MN) Hahn Stephen J. (Roseville MN) Lang Douglas J. (Arden Hills MN) Heil John E. (St. Paul MN), Body implantable defibrillation system.
Spinelli, Julio C.; Zhu, Qingsheng; Stahmann, Jeffrey E.; Kramer, Andrew P., Cardiac rhythm management system with arrhythmia classification and electrode selection.
Schwartz,Mark; Bocek,Joseph M.; Kim,Jaeho, Cardiac rhythm management systems and methods using multiple morphology templates for discriminating between rhythms.
Cox Michael W. (Lincroft NJ) Levin Richard I. (New York NY) Cohen David J. (Sag Harbor NY) Frisbie William R. (East Hampton NY), Cardiac signal real time monitor and method of analysis.
Langer Alois A. (2405 Velvet Valley Way Pittsburgh PA) Heilman Marlin S. (2405 Velvet Valley Way Gibsonia PA) Mower Morton M. (2405 Velvet Valley Way Baltimore MD) Mirowski Mieczyslaw (2405 Velvet Va, Circuit for monitoring a heart and for effecting cardioversion of a needy heart.
Sweeney, Robert J.; Lovett, Eric G., Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification.
Steinhaus Bruce M. (Parker CO) Wells Randy T. (Littleton CO), Data compression of cardiac electrical signals using scanning correlation and temporal data compression.
Van Hofwegen Lloyd (New Brighton MN) Hsung Jean-Cheui (Shoreview MN) Huntwork Daniel (Vadnais Heights MN), Defibrillation/cardioversion system with multiple evaluation of heart condition prior to shock delivery.
Steinhaus Bruce M. (Parker CO) Wells Randy T. (Littleton CO), Detection of cardiac arrhythmias using correlation of a cardiac electrical signals and temporal data compression.
Collins Kenneth A. (Neutral Bay AUX) Maker Philip J. (Sydney AUX), Implantable automatic and haemodynamically responsive cardioverting/defibrillating pacemaker with means for minimizing b.
Langer Alois A. (2405 Velvet Valley Way Pittsburgh PA) Kolenik Steve A. (2405 Velvet Valley Way Leechburg PA) Heilman Marlin S. (2405 Velvet Valley Way Gibsonia PA) Mirowski Mieczyslaw (2405 Velvet V, Implantable heart stimulator and stimulation method.
Hauser Robert G. ; Dahl Roger W. ; KenKnight Bruce H., Implantable intravenous cardiac stimulation system with pulse generator housing serving as optional additional electrode.
Levine Paul A. ; Sholder Jason A. ; Bornzin Gene A. ; Florio Joseph J. ; Valikai Kenneth ; Weinberg Lisa P., Implantable stimulation device having means for operating in a preemptive pacing mode to prevent tachyarrhythmias and method thereof.
Ghanem, Raja N.; Stadler, Robert W.; Zhang, Xusheng; Greenhut, Saul E.; Kleckner, Karen J.; Krause, Paul G.; Mahajan, Veerdhaval, Method and apparatus for detecting arrhythmias in a medical device.
Krause, Paul G.; Kleckner, Karen J.; Lu, Steven N.; Ritscher, David E.; Kaszas, Cameron J.; Hemming, Michael T., Method and apparatus for detecting noise in an implantable medical device.
Ghanem, Raja N.; Stadler, Robert W.; Zhang, Xusheng; Kleckner, Karen J.; Krause, Paul G., Method and apparatus for determining oversensing in a medical device.
Bardy Gust H. (Seattle WA) Olson Walter H. (North Oaks MN) Peterson David K. (Mounds View MN) Taepke Robert T. (Fridley MN), Method and apparatus for discrimination of ventricular tachycardia from ventricular fibrillation and for treatment there.
Kolenik Steve (Leechburg PA) Langer Alois A. (Pittsburgh PA), Method and apparatus for effecting automatic ventricular defibrillation and/or demand cardioversion through the means of.
Stadler Robert ; Nelson Shannon ; Stylos Lee ; Sheldon Todd J., Method and apparatus for filtering electrocardiogram (ECG) signals to remove bad cycle information and for use of physiologic signals determined from said filtered ECG signals.
Gunderson,Bruce D.; Patel,Amisha S.; Bounds,Chad A., Method and apparatus for identifying cardiac and non-cardiac oversensing using intracardiac electrograms.
Gunderson, Bruce D.; Patel, Amisha S.; Bounds, Chad A.; Brown, Mark L., Method and apparatus for identifying oversensing using far-field intracardiac electrograms and marker channels.
Riff Kenneth M. (Plymouth MN) McDonald Ray S. (Roseville MN) German Michael J. (Mounds View MN), Method and apparatus for intracardiac electrogram morphologic analysis.
Caswell Stephanie A. ; Jenkins Janice M. ; DiCarlo Lorenzo A., Method and apparatus for separation of ventricular tachycardia from ventricular fibrillation for implantable cardioverte.
Throne Robert D. (Ann Arbor) Jenkins Janice M. (Ann Arbor) DiCarlo Lorenzo A. (Ann Arbor MI), Method and system for monitoring electrocardiographic signals and detecting a pathological cardiac arrhythmia such as ve.
Zhou,Xiaohong; Gunderson,Bruce D.; Olson,Walter H.; Stadler,Robert W., Method for determining a metric of non-sustained arrhythmia occurrence for use in arrhythmia prediction and automatic adjustment of arrhythmia detection parameters.
Sarkar,Shantanu; Brown,Mark L, Methods and apparatus for discriminating polymorphic tachyarrhythmias from monomorphic tachyarrhythmias facilitating detection of fibrillation.
Olson Walter H. (North Oaks MN) Kaemmerer William F. (Edina MN), Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmias.
Gilli Norma L. (Mosman) Holley Lorraine (Rockdale) Drane Geoffrey A. (Annandale) Stephens Anthony C. (Willoughby) Daly Christopher N. (Bilgola Plateau AUX) Maas Steven M. (Englewood CO), Reconfirmation prior to shock for implantable defibrillation.
White Harley (Redmond WA) Bocek Joseph M. (Seattle WA), Selective cardiac activity analysis atrial fibrillation detection system and method and atrial defibrillator utilizing s.
Bennett Tom D. (Shoreview MN) Combs William J. (Eden Prairie MN) Kallok ; Michael J. (New Brighton MN) Lee Brian B. (Golden Valley MN) Mehra Rahul (Stillwater MN) Klein George J. (London CAX), Subcutaneous multi-electrode sensing system, method and pacer.
Florio, Joseph J., System and method for distinguishing electrical events originating in the atria from far-field electrical events originating in the ventricles as detected by an implantable medical device.
McClure, Kelly H.; Bornzin, Gene A.; Mai, Junyu, System and method of automatically adjusting sensing parameters based on temporal measurement of cardiac events.
Bocek Joseph M. ; Finch David P. ; Foshee ; Jr. Phillip D. ; Kim Jaeho, System for detecting atrial fibrillation notwithstanding high and variable ventricular rates.
Nabutovsky,Yelena; Farazi,Taraneh Ghaffari; Bjorling,Anders; Noren,Kjell; Bornzin,Gene A., Systems and methods for detection of VT and VF from remote sensing electrodes.
Siejko, Krzysztof Z.; Allavatam, Venugopal; Brisben, Amy Jean; Hahn, Stephen J.; Herrmann, Keith L., Methods and devices combining multiple cardiac rate measurements with interval correction and arrhythmia decision bypass.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.